Replenix
Replenix, licence 80087951: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Topix Pharmaceuticals, Inc.
- NPN or DIN-HM
- 80087951
- Status
- Active licence
- Licence date
- 22 August 2018
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Isostéarate de glycéryle, Polymère croisé d'acrylates-4, Acétate de dl-alpha tocophéryle, Cétyl phosphate de potassium, Phosphate de céteth-10, Cyclopentasiloxane, Acide poly(hydroxystéarique), Palmitate de rétinyle, Hydroxyde de potassium, Eau purifiée, Phospholipides, Acide L-ascorbique, Phosphate de dicétyle, EDTA de sodium, Lauryl PEG/PPG-18/18 méthicone, Cétyl PEG/PPG-10/1 Diméthicone, Biotine, Palmitate d'ascorbyle, Coenzyme Q10, Alcool cétéarylique, Extrait de fruits de Phyllanthus Emblica, Phénoxyéthanol, Diheptanoate de néopentylglycol, Gomme de xanthane, Resvératrol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | Not specified |
Uses authorised in Canada
Helps prevent sunburn. Broad Spectrum SPF 50+. If used as directed with other sun protection measures [see Directions for Use], decreases the risk of skin cancer and early skin aging caused by the sun.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. Do not use on damaged or broken skin. If rash occurs, discontinue use and consult a health care practitioner. When using this product keep out of eyes. Rinse with water to remove. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Source
Official Health Canada record, licence 80087951
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.